These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19798525)

  • 1. Optimal savings and health spending over the life cycle.
    Fioroni T
    Eur J Health Econ; 2010 Aug; 11(4):355-65. PubMed ID: 19798525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of governance, public spending on health and health status in Sub Saharan Africa: a panel data regression analysis.
    Makuta I; O'Hare B
    BMC Public Health; 2015 Sep; 15():932. PubMed ID: 26390867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hong Kong domestic health spending: financial years 1989/90 to 2008/09.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2012 Aug; 18(4 Suppl 4):1-23. PubMed ID: 22947491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2019 Jun; 393(10187):2233-2260. PubMed ID: 31030984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International health care spending.
    Schieber GJ; Puollier JP
    Health Aff (Millwood); 1986; 5(3):111-22. PubMed ID: 3098657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the Income Elasticity of Health Spending in Middle-Income and High-Income Countries: The Role of Financial Protection.
    Vargas Bustamante A; V Shimoga S
    Int J Health Policy Manag; 2018 Mar; 7(3):255-263. PubMed ID: 29524954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016-40.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2018 May; 391(10132):1783-1798. PubMed ID: 29678341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of preventive and curative health care in economic development.
    Wang F
    PLoS One; 2018; 13(11):e0206808. PubMed ID: 30403708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hong Kong domestic health spending: financial years 1989/90 to 2009/10.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
    Hong Kong Med J; 2013 Apr; 19(2 Suppl 3):1-24. PubMed ID: 23589588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hong Kong domestic health spending: financial years 1989/90 to 2011/12.
    Tin KY; Tsoi PK; Lee YH; Chong DS; Lam DW; Yeung AY; Ma ES; Maw CK
    Hong Kong Med J; 2015 Jun; 21(3 Suppl 3):1-24. PubMed ID: 26045183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resource allocation for pharmaceutical procurement in the Brazilian Unified Health System.
    Vieira FS; Zucchi P
    Rev Saude Publica; 2011 Oct; 45(5):906-13. PubMed ID: 21808832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spanish recommendations on economic evaluation of health technologies.
    López-Bastida J; Oliva J; Antoñanzas F; García-Altés A; Gisbert R; Mar J; Puig-Junoy J
    Eur J Health Econ; 2010 Oct; 11(5):513-20. PubMed ID: 20405159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future and potential spending on health 2015-40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2017 May; 389(10083):2005-2030. PubMed ID: 28433260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hong Kong domestic health spending: financial years 1989/90 to 2010/11.
    Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Yeung AY; Chui AW; Tay MS
    Hong Kong Med J; 2013 Dec; 19(6 Suppl 7):1-24. PubMed ID: 24356244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing costs and outcomes across programmes of health care.
    Martin S; Rice N; Smith PC
    Health Econ; 2012 Mar; 21(3):316-37. PubMed ID: 21322086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spending on medicines in Israel in an international context.
    Sax P
    Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental Health Policy in Brazil: federal expenditure evolution between 2001 and 2009.
    Gonçalves RW; Vieira FS; Delgado PG
    Rev Saude Publica; 2012 Feb; 46(1):51-8. PubMed ID: 22183515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical expenditure and gross domestic product: Evidence of simultaneous effects using a two-step instrumental variables strategy.
    Shaikh M; Gandjour A
    Health Econ; 2019 Jan; 28(1):101-122. PubMed ID: 30306669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scale Effects and Expected Savings from Consolidation Policies of Italian Local Healthcare Authorities.
    Di Novi C; Rizzi D; Zanette M
    Appl Health Econ Health Policy; 2018 Feb; 16(1):107-122. PubMed ID: 29124677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2018 May; 391(10132):1799-1829. PubMed ID: 29678342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.